As of 2024-12-13, the Relative Valuation of Cortexyme Inc (CRTX) is (24.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.95 USD, the upside of Cortexyme Inc based on Relative Valuation is -1369.8%.
The range of the Relative Valuation is (15.44) - (26.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 24.4x | 17.5x |
| Forward P/E multiples | 11.3x - 19.1x | 18.8x |
| Fair Price | (15.44) - (26.09) | (24.76) |
| Upside | -892.0% - -1437.7% | -1369.8% |
| Date | P/E |